, Volume 27, Issue 1, pp 47–56 | Cite as

Resveratrol ameliorates gouty inflammation via upregulation of sirtuin 1 to promote autophagy in gout patients

  • Qi-Bin YangEmail author
  • Yong-Long He
  • Xiao-Wu Zhong
  • Wen-Guang Xie
  • Jing-Guo ZhouEmail author
Original Article



Resveratrol exerts an anti-inflammatory effect on collagen-induced arthritis and osteoarthritis in rats via activation of sirtuin 1 (SIRT1). Autophagy can be induced by resveratrol and leads to amelioration of interleukin-1 beta (IL-1β) release in vitro. We aimed to determine the anti-inflammatory mechanisms of resveratrol in patients with gout.


Blood samples were obtained from patients with acute gout, intercritical gout (IG) and healthy controls (HC). The mRNA and protein levels of SIRT1 and nuclear factor-kappa B (NF-kB) p65 were determined in peripheral blood mononuclear cells (PBMCs) lysate from these patients. In the in vitro experiment, SIRT1, autophagy-related genes (beclin-1 and microtubule-associated protein 1 light-chain 3) and key genes involved in the gouty inflammatory pathway, including NF-κB p65, NLR family pyrin domain containing 3 (NLRP3), caspase-1 and IL-1β, were determined in PBMCs lysate or plasma from IG patients exposed to monosodium urate (MSU) crystals with or without resveratrol.


The mRNA and protein levels of SIRT1 were downregulated in PBMCs from gout patients in comparison with HC. In the in vitro experiment, the protein levels of SIRT1 were downregulated in PBMCs from IG patients exposed to MSU crystals and were restored by resveratrol in a dose-dependent manner. Furthermore, high doses of resveratrol ameliorated the release of the inflammatory cytokine IL-1β. In addition, the mRNA levels of NLRP3 and NF-κB p65 were regulated by resveratrol, but caspase-1 and IL-1β were not. Furthermore, resveratrol promoted MSU-induced autophagy in PBMCs from patients with gout.


These findings suggest that resveratrol ameliorates gouty inflammation via upregulation of SIRT1 to promote autophagy in patients with gout.


Resveratrol Sirtuin 1 Autophagy Gout 



This research was supported partly by the National Natural Science Foundation of China (81670801, 81800776), Sichuan Science and Technology Program (2017JY0037, 2018JY0498), Education Agency of Sichuan Province (15ZB0202), Sichuan Medical Association (S16027), Sichuan Health and Family Planning Commission (17PJ059) and Science and Technology Strategic Cooperation Program between Nanchong City and University (NSMC170429).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.


  1. Baur JA (2010) Resveratrol sirtuins and the promise of a DR mimetic. Mech Ageing Dev 131:261–269. CrossRefGoogle Scholar
  2. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506. CrossRefGoogle Scholar
  3. Carneiro LA, Travassos LH (2013) The interplay between NLRS and autophagy in immunity and inflammation. Front Immunol 4:361. CrossRefGoogle Scholar
  4. Chen CJ et al (2006) MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Investig 116:2262–2271. CrossRefGoogle Scholar
  5. Choi AM, Ryter SW, Levine B (2013) Autophagy in human health and disease. New Engl J Med 368:651–662. CrossRefGoogle Scholar
  6. Du Jin-feng LF, Jing Tian, Xi Xie, Jin-wei Chen, Jie-Sheng Gao (2009) The anti-inflammatory effect of Resveratrol on collagen-induced arthritis rats. Chin J Rheumatol 13:123–126Google Scholar
  7. Elmali N, Esenkaya I, Harma A, Ertem K, Turkoz Y, Mizrak B (2005) Effect of resveratrol in experimental osteoarthritis in rabbits. Inflamm Res Off J Eur Histamine Res Soc 54:158–162. Google Scholar
  8. Getting SJ, Christian HC, Flower RJ, Perretti M (2002) Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. Arthritis Rheum 46:2765–2775. CrossRefGoogle Scholar
  9. Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Ann Rev Pathol 5:253–295. CrossRefGoogle Scholar
  10. Howitz KT et al (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196. CrossRefGoogle Scholar
  11. Jones SA, Mills KH, Harris J (2013) Autophagy and inflammatory diseases. Immunol Cell Biol 91:250–258. CrossRefGoogle Scholar
  12. Levine B, Mizushima N, Virgin HW (2011) Autophagy in immunity and inflammation. Nature 469:323–335. CrossRefGoogle Scholar
  13. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402–408. CrossRefGoogle Scholar
  14. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241. CrossRefGoogle Scholar
  15. Qing YF, Zhang QB, Yang QB, Xie WG, Zhou JG (2014a) Altered expression of NLRP3 inflammasome in peripheral blood from gout patients might be associated with gouty arthritis. Gout Hyperuricemia 1:25–32. Google Scholar
  16. Qing YF, Zhang QB, Zhou JG, Jiang L (2014b) Changes in toll-like receptor (TLR)4-NFkappaB-IL1beta signaling in male gout patients might be involved in the pathogenesis of primary gouty arthritis. Rheumatol Int 34:213–220. CrossRefGoogle Scholar
  17. Shi CS et al (2012) Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13:255–263. CrossRefGoogle Scholar
  18. Shintani T, Klionsky DJ (2004) Autophagy in health and disease: a double-edged sword. Science 306:990–995. CrossRefGoogle Scholar
  19. Stark K et al (2008) Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS ONE 3:e1948. CrossRefGoogle Scholar
  20. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 20:895–900CrossRefGoogle Scholar
  21. Wang B et al (2014) Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice. J Cell Mol Med 18:1599–1611. CrossRefGoogle Scholar
  22. Weavers H, Evans IR, Martin P, Wood W (2016) Corpse engulfment generates a molecular memory that primes the macrophage inflammatory response. Cell 165:1658–1671. CrossRefGoogle Scholar
  23. Wu Y et al (2011) Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson’s disease. Neuro-Signals 19:163–174. CrossRefGoogle Scholar
  24. Wu J, Li X, Zhu G, Zhang Y, He M, Zhang J (2016) The role of Resveratrol-induced mitophagy/autophagy in peritoneal mesothelial cells inflammatory injury via NLRP3 inflammasome activation triggered by mitochondrial ROS. Exp Cell Res 341:42–53. CrossRefGoogle Scholar
  25. Xuzhu G, Komai-Koma M, Leung BP, Howe HS, McSharry C, McInnes IB, Xu D (2012) Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann Rheum Dis 71:129–135. CrossRefGoogle Scholar
  26. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369–2380. CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Rheumatology and ImmunologyThe Affiliated Hospital of North Sichuan Medical CollegeNanchongChina
  2. 2.Clinical Medical SchoolChengdu University of TCMChengduChina
  3. 3.Department of Clinical LaboratoryThe Affiliated Hospital of North Sichuan Medical CollegeNanchongChina
  4. 4.Department of Rheumatology and ImmunologyThe First Affiliated Hospital of Chengdu Medical CollegeChengduChina

Personalised recommendations